James Kihara Acadia Pharmaceuticals Inc (ACAD) insider trading activity

ACAD Quotes by TradingView

James Kihara is PRINCIPAL ACCOUNTING OFFICER of ACADIA PHARMACEUTICALS INC. Currently has a direct ownership of 21,275 shares of ACAD, which is worth approximately $363,164. The most recent transaction as insider was on Feb 23, 2023, when has been sold 840 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.3K
7.11% 3M change
86.77% 12M change
Total Value Held $363,164

James Kihara Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 23 2023
BUY
Exercise of conversion of derivative security
-
840 Added 20.42%
3,273 Common Stock
Apr 08 2022
SELL
Open market or private sale
$27,726 $27.05 p/Share
1,025 Reduced 29.64%
2,433 Common Stock
Apr 07 2022
BUY
Exercise of conversion of derivative security
-
2,977 Added 46.26%
3,458 Common Stock
Feb 23 2022
SELL
Open market or private sale
$8,544 $23.8 p/Share
359 Reduced 42.74%
481 Common Stock
Feb 23 2022
BUY
Exercise of conversion of derivative security
-
840 Added 50.0%
840 Common Stock
JK

James Kihara

PRINCIPAL ACCOUNTING OFFICER
San Diego, CA

Track Institutional and Insider Activities on ACAD

Follow ACADIA PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACAD shares.

Notify only if

Insider Trading

Get notified when an Acadia Pharmaceuticals Inc insider buys or sells ACAD shares.

Notify only if

News

Receive news related to ACADIA PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ACAD